Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Reason #4: We dont know enough yet This is perhaps the most honest reason: the absence of data isnt the same as data showing safety
Tirzepatide, in particular, is a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonistoften referred to as a twincretinwith greater activity at the GIP receptor
NDC=National Drug Code
If not, we want to see how we can moderate our protocols so that the patient undergoing a total hip arthroplasty who is also taking a GLP-1 agonist can have the most ideal experience possible for their surgery.
The two are independent interventions
Editorial Advisory Board Member, Harvard Health Publishing The GLP-1 drugs, which include semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro, Zepbound), are turning out to have effects that go beyond shedding pounds and controlling diabetes
